1. Abraham KA, Kenelly M, Dorman AM, Walshe JJ. Pathogenesis of acute renal failure associated with the HELLP syndrome: a case report and review of the literature. Eur J Obstet Gynecol Repr Biol 2003; 108:99-102.
2. Abroug F, Boujdaria R, Nouira S, Abroug S, Souissi M, Najjar MF, Secourgeon JF, Bouchoucha S. HELLP-syndrome: incidence and maternal-fetal outcome- a prospective study. Intensive Care Med 1992; 18:274-277.
3. Aya AG, Mangin R, Vialles N, Ferrer JM, Robert C, Ripart J, de La Coussaye JE. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective caesarean section delivery than healthy parturients: A prospective cohort comparison. Anesth Analg 2003; 97:867-872.
4. Asztalos M. A toxaemia, eclampsia etiológiája az újabb ismeretek tükrében.
Magy Nőorv L 1994; 57:381-382.
5. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria fort the HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome Am J Obstet Gynecol 1996; 175:460-464.
6. Barton JR, Riely CA, Adamec TA, Shanklin DR, Khoury AD, Sibai BM.
Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes and low platelet count). Am J Obstet Gynecol 1992, 167:1538-1543.
7. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996;
174:1820-1827.
8. Baxter JK, Weinstein L. HELLP syndrome: The state of the Art. Obstet Gynecol Surv 2004; 59:838-845.
9. Beilin Y, Bodian CA, Haddad EM, Leibowitz AB. Practice patterns of anesthesiologists regarding situations in obstetrics anesthesia where clinical management is controversial. Anesth Analg 1996; 83:735-741.
10. Beilin Y, Zahn J, Comeford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 per mm3. Anesth Analg 1997;
85:385-388.
11. Benedetto C, Marozio L, Salton L, Maulá V, Chieppa G, Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 2002; 81:1095-1100.
12. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
13. Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeclampsia Eur J Obstet Gynecol Reprod Biol 2001; 96:8-20.
14. Bozzo M, Carpani G, Leo L, Marcozzi S, Sacchi E, Moroni G, Pardi G. HELLP syndrome and factor V Leiden. Eur J Obstet Gynecol Reprod Biol 2001; 95:55- 58.
15. Brenner B, Lanir N, Thaler I. HELLP-syndrome associated with factor V R506 Q mutation. Br J Haematol 1996; 92:999-1001.
16. Briggs R, Chari RS, Mercer B, Sibai B. Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): Does delayed primary closure make a difference? Am J Obstet Gynecol 1996; 175:893-896.
17. Bromage PR. Neurologic complications of regional anesthesia for obstetrics. In:
Shnider SM. and Levinson G. editors, Anesthesia for obstetrics (3rd ed.), Williams&Willkins, Baltimore (1993), 443-444.
18. Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP syndrome at ≤ 28 weeks of gestation. Am J Obstet Gynecol 2003; 188:1504-1508.
19. Chiu CL, Mansor M, Ng KP, Chan YK. Retrospective review of spinal versus epidural anaesthesia for caesarean section in preeclamptic patients. Int J Obstet Anesth 2003; 12:23-27.
20. Crosby ET. Obstetrical anaesthesia for patients with the syndrome of haemolysis, elevated liver enzymes and low platelets. Can J Anaesth 1991;
38:227-233.
21. Crosby ET, Preston R. Obstetrical anaesthesia for parturient with preeclampsia, HELLP syndrome and acute cortical blindness. Can J Anaesth 1998; 45:452- 459.
22. Cunningham DS, Christiet TL, Evans EE, McCaul JF. Effect of the HELLP- syndrome on maternal immune function. Reprod Med 1993; 38:459-464.
23. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Proc Natl Acad Sci USA. 1993; 90:1004-1008.
24. Dahlback B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med 1995; 237:221- 227.
25. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995; 85:607-614.
26. de Belder A, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP- syndrome with nitric oxide donor. Lancet 1995; 345:124-125.
27. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oei SG, Kanhai HH, Rosendaal FR.
Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999, 181:975-980.
28. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, van Geijn HP. Underlying disorders associated with severe early- onset preeclampsia. Am J Obstet Gynecol 1995; 173:1042-1048.
29. Detti L, Mecacci F, Piccioli A, Ferrarello S, Carignani L, Mello G, Ferguson JE, Scarselli G. Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications. J Perinatol. 2005; 25:236-240.
30. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175:902-905.
31. Duffy BL. HELLP syndrome and the anaesthetist. Anaesthesia 1988; 43:223- 225.
32. Editorial: The bleeding time. Lancet 1991; 337:1447-1448.
33. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999; 42:381- 389.
34. Esan K, Moneim T, Page IJ. Postpartum HELLP syndrome after a normotensive pregnancy. Br J Gen Pract 1997; 47:441-442.
35. Forster JG, Peltonen S, Kaaja J, Lampinen K, Pettila V: Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand 2002; 46:955- 958.
36. Geary M. The HELLP syndrome. Br J Obstet Gynaecol 1997; 104:887-891.
37. Goodlin RC, Holdt D. Impending gestosis. Obstet Gynecol 1985; 58:743-745.
38. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77:1052-1054.
39. Guyer C. Severe postpartum HELLP syndrome. J Obstet Gynaecol 2000;
20:194.
40. Haeger M, Unander M, Bengtsson A. Enhanced anaphylatoxin and terminal C5b-9 complement complexformation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1990;
76:698-702.
41. Haddad B, Barton JR, Livingstone JC, Chahine R, Sibai BM. Risk factors for adverse maternal outcome among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;
183:444-448.
42. Halim A, Kanayama N, Maehara K, Takahashi M, Terao T. HELLP syndrome- like biochemical parameters obtained with endothelin-1 injections to rabbits.
Gynecol Obstet Invest 1993; 35:193-198.
43. Haram K, Trovik J, Sandset PM, Hordnes K. Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid antibody syndrome. Acta Obstet Gynecol Scan 2003; 82:679-680.
44. Hew-Wing P, Rolbin SH, Hew E, Amato D. Epidural anaesthesia and thrombocytopenia. Anaesthesia 1989; 44:775-777.
45. Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclampsitc, normotensive pregnant, and nonpregnant women.
Am J Obstet Gynecol 2004; 190:1128-1134.
46. Hood DD, Curry RRN. Spinal versus epidural anesthesia for caesarean section in severely preeclamptic patients: a retrospective survey Anesthesiology 1999;
90:1276-1282.
47. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr.
Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181:924-928.
48. Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN JR. A prospective, randomized trial comparing the efficacy of dexamethasone and betamathasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001; 184:1332-1339.
49. Isler CM, Magann EF, Rinehart BK, Terrone DA, Bass JD, Martin JN Jr.
Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet. 2003. 80:291-297.
50. Isler CM, Rinehart BK, Terrone DA, Magann EF, Martin JN Jr. The importance of parity to major maternal morbidity in the eclamptic mother with HELLP syndrome Hypertens Pregnancy 2003; 22:287-294.
51. Jouppila P, Jouppila R, Hollmen A, Koivula A. Lumbar epidural analgesia to improve intervillous blood flow during labor in severe preeclampsia. Obstet Gynecol 1982; 59:158-161.
52. Kahra K, Draganov B, Sund S, Hovig T. Postpartum renal failure: A complex case with probable coexistence of hemolysis, elevated liver enzymes, low platelet count, and haemolytic uremic syndrome. Obstet Gynecol 1998; 92:698- 700.
53. Kam PCA, Thompson SA, Liew ACS. Thrombocytopenia in the parturient.
Anaesthesia 2004; 59:255-264.
54. Katz VL, Watson WJ, Thorp JM Jr, Hansen W, Bowes WA Jr. Treatment of persistent postpartum HELLP-syndrome with plasmapheresis. Am J Perinatol 1992; 9:120-122.
55. Killam AP, Dillard SH, Patton RC, Pederson PR. Pregnancy-induced hypertension complicated by acut liver disease and disseminated intravascular coagulation. Five case reports Am J Obstet Gynecol 1975; 123:823-828.
56. Kitzmiller JL, Lang JE, Yelenosky PF, Lucas WE. Hematologic assays in preeclampsia. Am J Obstet Gynecol 1974; 118:362-367.
57. Knapen MFCM, Mulder TPJ, Bisseling JGA, Penders RHMJ, Peters WHM, Steegers EAP. Plasma glutathione S-transferase alpha 1-1: A more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1998; 178:161-165.
58. Krauss T, Augustin HG, Osmers RG, Meden H, Unterhalt M, Kuhn W.
Activated protein C resistance and factor Leiden in patients with HELLP syndrome. Obstet Gynecol 1998; 92:457-460.
59. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
60. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96:45-49.
61. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B.
Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997; 176:457-460.
62. Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B.
Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81:532-537.
63. Livingstone JC, Barton JR, Park V, Haddad B, Philips O, Sibai BH. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185:153-157.
64. Lurie S, Sadan O, Glezerman M, Ezri T. Pseudocholinesterase deficiency associated with HELLP syndrome. Am J Perinatol 2004; 21:315-317.
65. Magann EF, Roberts WE, Perry KG, Chauhan SP, Blake PG, Martin JN Jr.
Factors relevant to mode of preterm delivery with syndrome of HELLP
(hemolysis, elevated liver enzymes and low platelets). Am J Obstet Gynecol 1994; 170:1828-1842.
66. Magann EF, Bass D, Cauhan SP, Sullivan DL, Martin RW, Martin JN. Jr.
Antepartum corticosteroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 1994; 171:1148-1153.
67. Magann EF, Perry KG Jr, Meydrech EF, Harris RL, Chauhan SP, Martin JN Jr.
Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 1994; 171:1154-1158.
68. Magann EF, Martin JE. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999; 42:532-550.
69. Mandal NG, Surapaneni S. Regional anaesthesia in pre-eclampsia Drugs 2004;
64:223-236.
70. Martin JN Jr, Files JC, Blake PG, Norman PH, Martin RW, Hess LW, Morrison JC, Wiser WL. Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclapmsia with HELLP syndrome Am J Obstet Gynecol 1990; 162:128-137.
71. Martin JN Jr, Blake PG, Lowry SL, Perry KG Jr, Files JC, Morrison JC.
Pregnancy complicated by pre-eclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes and low platelet count: how rapid is postpartum recovery. Obstet Gynecol 1990; 76:737-741.
72. Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP-syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164:1500-1513.
73. Martin JN Jr, Perry KG Jr, Miles JF Jr, Blake PG, Magann EF, Roberts WE, Martin RW. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 1993; 100:1095-1100.
74. Martin JN Jr, Files JC, Blake PG, Perry KG Jr, Morrison JC, Norman PH:
Postpartum plasma exchange for atypical preeclampsia-eclapmsia as HELLP
(hemolysis, elevated liver enzymes, low platelets) syndrome. Am J Obstet Gynecol 1995; 172:1107-1127.
75. Martin JN Jr, Perry KG Jr, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome.
Am J Obstet Gynecol 1997; 177:1011-1017.
76. Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180:1407-1414.
77. Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification Am J Obstet Gynecol 1999; 180:1373-1384.
78. Martin JN Jr, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome Am J Obstet Gynecol 2003; 189:830-834.
79. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246-254.
80. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy.
Cochrane Database Syst Rev CD002076 2004.
81. McDonagh RJ, Ray JG, Burrows RF, Burrows EA, Vermeulen MJ. Platelet count may predict abnormal bleeding time among pregnant women with hypertension and preeclampsia. Can J Anaesth 2001; 48:563-569.
82. McKay DG. Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Surv 1972; 27:399-417.
83. Mecacci F, Carignani L, Cioni R, Parretti E, Mignosa M, Piccioli A, Scarselli G, Mello G. Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone. Thromb Res 2002; 102:99- 105.
84. Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP.
Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 2004; 103:1055-1058.
85. Meződy M, Diószeghy Cs, Pénzes I. HELLP-syndroma, mint a terhességi toxicosisok különleges formája. Orv Hetil 1995; 50:2733-2736.
86. Minakami H, Koimura Y, Izumi A, Watanabe T, Matsubara S, Sato J. Relation between gestational thrombocytopenia and the HELLP syndrome. Gynecol Obstet Invest 1998; 46:41-45.
87. Moodley J, Jjuuko G, Rout C. Epidural compared with general anaesthesia for caesarean delivery in conscious women with eclampsia Br J Obstet Gynaecol 2001; 108:378-382.
88. Mushambi MC, Halligan AW, Williamson K. Recent developments in the pathophysiology and management of prae-eclampsia. Br J Anaesth 1996;
76:133-148.
89. Nagy B, Tóth T, Rigó J Jr, Karádi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet 1998;
53:478-481.
90. Newsome LR, Bramwell RS, Curling PE. Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia Anesth Analg 1986; 65:31-36.
91. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991, 165:724- 727.
92. Obstetric Analgesia and Anesthesia. ACOG Practice Bulletin No.36. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 100:177-191.
93. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183:921-924.
94. O’Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: Impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002; 186:475-479.
95. O'Brien JM, Poynter L, Barton JR. Transfusion for hemolysis, elevated liver function tests, and low platelet count in pregnancy Int J Gynecol Obstet 2005;
89:291-292.
96. O'Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome Clin Obstet Gynecol 2005; 48:460-477.
97. Orlikowski CE, Rocke DA, Murray WB, Gouws E, Moodley J, Kenoyer DG, Byrne S. Thrombelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 1996; 77:157-161.
98. Osmers RGW, Schütz E, Diedrich F, Wehry B, Krauß T, Oellerich M, Kuhn W.
Increased serum levels of hyaluronic acid in pregnancies complicated praeeclampsia or hemolysis, elevated liver enzymes and low platelets syndrome.
Am J Obstet Gynecol 1998; 178:341-345.
99. Papp Z. (Szerk.) A szülészet és nőgyógyászat tankönyve. Semmelweis Kiadó, Budapst, 2002.
100. Patterson KW, O'Toole DP. HELLP syndrome: a case report with guidelines for diagnosis and management. Br J Anaesth 1991; 66:513-515.
101. Perry KG, Martin JN. Abnormal hemostasis and coagulopathy in pre-eclampsia and eclampsia. Clin Obstet Gynecol 1992; 35:338-350.
102. Polley LS. Anesthetic management of hypertension in pregnancy. Clin Obstet Gynecol 2003; 46:688-699.
103. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;
88:3698-3703.
104. Pritchard JA, Weisman R, Ratnoff OD, Vosburgh GJ. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 1954; 250:89-89.
105. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia:
their frequency and pathogenesis. Am J Obstet Gynecol 1976; 124:855-864.
106. Rath W, Loose W, Graeff H. The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1990; 36:43-51.
107. Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J Perinat Med 2000;
28:249-260.
108. Reck T, Bussenius-Kammerer M, Ott R, Muller V, Beinder E, Hohenberger W.
Surgical treatment of HELLP syndrome-associated liver rupture -- an update.
Eur J Obstet Gynecol Reprod Biol 2001; 99:57-65.
109. Redman CWG, Sargent IL. Prreclampsia, the placenta and the maternal systematic inflammatory response – A review Placenta 2003, 24 Suppl; 27:S21- S27.
110. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;
346:1133-1134.
111. Reubinoff BE., Schenker JG. HELLP-syndrome a syndrome - of hemolysis, elevated liver enzymes and low platelet count - complicating preeclampsia- eclampsia. Int J Gynecol Obstet 1991; 36:95-102.
112. Richa F, Yazigi A, Nasser E, Dagher C, Antakly MC. General anesthesia with remifentanil for Cesarean section in a patient with HELLP syndrome. Acta Anaesthesiol Scand. 2005; 49:418-420.
113. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
114. Riely CA. Hepatic disease in pregnancy. Am J Med 1994; 96:18S-22S.
115. Rigó J Jr, Nagy B, Fintor L, Tanyi J, Beke A, Karádi I, Papp Z. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy. 2000; 19:163-172.
116. Roberts WE, Perry KG Jr, Woods JB, Files JC, Blake PG, Martin JN Jr. The intrapartum platelet count in patient with HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome is it predictive of later hemorrhagic complications? Am J Obstet Gynecol 1994; 171:799-804.
117. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1-20.
118. Roelofsen AC, van Pampus MG, Aarnoudse JG. The HELLP-syndrome;
maternal-fetal outcome and follow up of infants. J Perinat Med. 2003; 31:201- 208.
119. Rolbin SH, Abbott D, Musclow E, Papsin F, Lie LM, Freedman J. Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol 1988;
71:918-920.
120. Rose CH, Thigpen BD, Bofill JA, Cushman J, May WL, Martin JN Jr. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol 2004; 104:1011-1014.
121. Rotmensch S, Liberati M, Mittlemann M, Ben-Rafael Z. Activated protein C resistance and adverse pregnancy outcome. Am J Obstet Gynecol 1997;
177:170-173
122. Santema JG, Koppelaar I, Wallenburg HC. Hypertension disorders in twin pregnancy. Eur J Obstet Gynecol Reprod Biol 1995; 58:9-13.
123. Saura P, Blanch L, Capdevila E, Baigorri F, Martin J, Corona M, Artigas A.
Spontaneous rupture of the liver during pregnancy. Intensive Care Med 1995;
21:95-96.
124. Schlenzig C, Maurer S, Goppelt M, Ulm K, Kolben M. Postpartum curettage in patents with HELLP syndrome does not result in accelerated recovery Eur J Obstet Gynecol Repsod Biol 2000; 91:25-28.
125. Schrocksnadel H, Sitte B, Steckel-Berger G, Dapunt O. Hemolysis in hypertensive disorders of pregnancy. Gynecol Obstet Invest 1992; 34:211-216.
126. Schwartz ML, Brenner W. Toxemia in a patient with none of the standard signs and symptoms of preeclampsia. Obstet Gynecol 1985; 66:19S-21S.
127. Seige M, Schweigart U, Moessmer G, Schneider KT, Classen M. Extensive hepatic infarction caused by thrombosis of right portal vein branches and arterial vasospasm in HELLP syndrome associated with homozygous factor V Leiden.
Am J Gastroenterol 1998; 93:473-474.
128. Seligman SP, Buyon JP, Clancy RM, Zoung BK, Abramson SB. The role of nitric oxide in the pathogenesis of pre-eclampsia. Am J Obstet Gynecol 1994;
171:944-948.
129. Sharwood-Smith G, Clark V, Watson E. Regional anaesthesia for caesarean section in severe preeclampsia: spinal anaesthesia is the preferred choice. Int J Obstet Anesth 1999; 8:85-89.
130. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal- perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155:501-509.
131. Sibai BM. The HELLP-syndrome (hemolysis, elevated liver enzymes, low platelets) much ado about nothing? Am J Obstet Gynecol 1990; 162:311-316.
132. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA.
Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP-syndrome). Am J Obstet Gynecol 1993; 169:1000-1006.
133. Sibai BM, Ramadan MK. Acut renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168:1682-1690.
134. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, low platelets):
Subsequent pregnancy outcome and long term prognosis. Am J Obstet Gynecol 1995; 172:125-129.
135. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181-192.
136. Strand S, Strand D, Seufert R, Mann A, Lotz J, Blessing M, Lahn M, Wunsch A, Broering DC, Hahn U, Grischke EM, Rogiers X, Otto G, Gores GJ, Galle PR.
Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology. 2004; 126:849- 858.
137. Sullivan CA., Magann EF, Perry KG Jr, Roberts WE, Blake PG, Martin JN Jr.
The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994;
171:940-943.
138. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefit of corticosteroids. Am J Obstet Gynecol 1999; 181:304-309.
139. Yuen TST, Kua JSW, Tan IKS. Spinal haematoma following epidural anaesthesia in a patient with eclampsia. Anaesthesia 1999; 54:350-354.
140. Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F.
Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol 1989;
73, 97-102.
141. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulnts and spinal-epidural anesthesia Anesth Analg 1994; 79:1165-1177.
142. van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, Buller HR. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999;
180:1146-1150.
143. van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001; 20:15-23.
144. van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 2005; 60:57-70.
145. Vigil-De Gracia P, Silva S, Montufar C, Carrol, De Los Rios S. Anesthesia in pregnant women with HELLP syndrome. Int J Gynaecol Obstet 2001; 74:23-27.
146. Vigil-De Gracia P. Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders. Int J Gynaecol Obstet 2001; 73:215-220.
147. Vigil-De Gracia P. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int J Gynecol Obstet 2001; 72:17-23.
148. Vincelot A, Nathan N, Collet D, Mehaddi Y, Grandchamp P, Julia A. Platelet function during pregnancy: an evaluation using the PFA-100 analyser Br J Anaesth 2001; 87:890-893.